Medical News

RSS

BMA appeals for widespread support for Smoke-Free Liverpool

The first reading of the Private Bill to ban all smoking in Liverpool workplaces is being presented in the House of Lords today. Mr James Johnson, BMA Chairman and a vascular surgeon working around Liverpool, has called for mass support of the Bill.

24 Jan 2005

Breast augmentation top cosmetic procedure for women carried out in UK

The British Association of Aesthetic Plastic Surgeons has announces the results of their annual audit for the period ending 31 March 2004.

24 Jan 2005

Nasogastric tube after abdominal surgery slows recovery

Routine use of a nasogastric tube after abdominal surgery, once thought to speed the return of normal intestinal functions, actually slows recovery, according to a new review of research.

24 Jan 2005

Vaginal hysterectomies better than abdominal hysterectomies

A review of recent studies concludes that surgeons should perform vaginal rather than abdominal hysterectomies whenever possible in order to cut down on complications and the length of hospital stays.

24 Jan 2005

Orally ingested drug to help Type 2 diabetes sufferers

A new drug invented by Monash University researchers Paul Zimmet and Frank Ng could help Type 2 diabetes sufferers lower blood glucose levels and enhance the potency of insulin, with few side effects.

24 Jan 2005

Use of anti-inflammatory steroids for traumatic head injuries may actually increase the risk of death

The common use of anti-inflammatory steroids for traumatic head injuries like those from car crashes may actually increase the risk of death, according to a new review of studies about the treatment.

24 Jan 2005

Distraction osteogenesis procedure may be a feasible and effective method to repair cleft palate in the future

Results from a Mayo Clinic laboratory study in animals suggest that using distraction osteogenesis, a procedure that uses the mechanical force of an appliance to lengthen soft tissue and bone, may be a feasible and effective method to repair cleft palate in the future.

24 Jan 2005

Organon’s compound, Org 24448, selected to test efficacy of cognitive dysfunction in schizophrenia

The National Institute of Mental Health (NIMH) sponsored network called Treatment Units for Research on Neurocognition in Schizophrenia (TURNS) has selected Organon’s compound, Org 24448, to undergo testing as part of its effort to facilitate the development of medications to enhance cognition in patients with schizophrenia.

24 Jan 2005

Scientists answer the question, why do some people always seem to get bitten by mosquitoes more than others?

Now scientists from the United Kingdom's Rothamsted Research Centre, the largest agricultural research centre in the United Kingdom are asking why some people always seem to get bitten by mosquitoes more than others? These scientists believe they may have found the answer and their work could lead to the development of novel insect repellents.

24 Jan 2005

Call for Anastrozole (Arimidex) to be the new preferred breast cancer treatment option

An international group of breast cancer experts called for the aromatase inhibitor (AI), anastrozole ('Arimidex'), to be considered as the new 'preferred treatment option' for postmenopausal women with early breast cancer.

24 Jan 2005

Available lines of human embryonic stem cells have been contaminated

Currently available lines of human embryonic stem cells have been contaminated with a non-human molecule that compromises their potential therapeutic use in human subjects, according to research by investigators at the University of California, San Diego (UCSD) School of Medicine and the Salk Institute in La Jolla, California.

24 Jan 2005

Activate dendritic cells turn on biological clock

A molecule specially modified by researchers at Baylor College of Medicine can reset the biological clock for cancer vaccines, potentially making them more potent.

24 Jan 2005

Priming embryonic stem cells to fulfill their promise

Bioengineering researchers at the University of California, San Diego have invented a process to help turn embryonic stem cells into the types of specialized cells being sought as possible treatments for dozens of human diseases and health conditions.

24 Jan 2005

High blood pressure risk in African-Americans linked to genetics

National health records have shown that African-Americans are more prone to high blood pressure than Caucasians, but pinning down the roots of that difference has proven elusive. Now, researchers at the Stanford University School of Medicine have narrowed down the search for genes that contribute to this difference in disease risk.

24 Jan 2005

No association between neuroticism and extroversion – and cancer

There is no association between two specific personality traits – neuroticism and extroversion – and cancer, according to a new study, one of the largest prospective twin studies to examine this issue.

24 Jan 2005

Over-eating at an early age may stay well into adulthood

Melbourne researchers have found that over-eating at a very young age can have a long-lasting effect on the body and in particular seems to enhance the production of hormones made in fat and involved in metabolism.

24 Jan 2005

Early seizures after surgery for epilepsy predict more seizures

Current understanding of seizures in the weeks just after epilepsy surgery is that they are likely to be temporary, probably due to swelling or minor trauma suffered by the brain during the operation.

24 Jan 2005

Obesity is linked to lower levels of prostate specific antigen (PSA) in men

A study reported in the current issue of Cancer, the journal of the American Cancer Society, shows that obesity is linked to lower levels of prostate specific antigen (PSA) in men, making early detection tests unreliable.

24 Jan 2005

Clinical trial planned for stem cell treatment for stress urinary incontinence

ITL Laboratories, L.L.C. ("ITL") is planning a clinical trial to determine the effectiveness of a stem cell treatment for stress urinary incontinence. A recent clinical trial by Austrian researchers has demonstrated the potential usefulness of expanded muscle stem cell injections in the treatment of urinary incontinence.

24 Jan 2005

Health authorities reviewing scientific data from trials evaluating Alzheimer's treatment, Reminyl

Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.

24 Jan 2005